I agree that this site is using cookies. You can find further informations here.
X
Zuiverloon, T.
49  results:
Search for persons X
?
1

PRIMETEST II – trial to test new predictors of recurrence i..:

Che, Y. ; Zuiverloon, T. ; Arnout, A....
European Urology.  83 (2023)  - p. S754 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Molecular markers (FGFR3 mutation; p53 and Ki-67 expression..:

Van Rhijn, B.W.G. ; Mertens, L. ; Mayr, R....
European Urology Supplements.  18 (2019)  1 - p. e819 , 2019
Link: https://doi.org/10.1016/..
 
?
3

FGFR3 mutations and their relation to FGFR3 expression and ..:

Mertens, L.S. ; Van Rhijn, B.W.G. ; Mayr, R....
European Urology Supplements.  18 (2019)  1 - p. e1450-e1451 , 2019
Link: https://doi.org/10.1016/..
 
?
4

MP-2.17: Feasibility Study of Population-Based Screening fo..:

Roobol, M. ; Zuiverloon, T. ; Zwarthoff, E....
Urology.  72 (2008)  5 - p. S72 , 2008
Link: https://doi.org/10.1016/..
 
?
5

GATA2 methylation and FGFR3 mutation predict progression in..:

Olislagers, M. ; De Jong, F.C. ; Van Etten, V.M.J...
European Urology.  83 (2023)  - p. S405-S406 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Sequential intravesical Gemcitabine and Docetaxel as salvag..:

Pijpers, O.M. ; De Jong, J.J. ; Zee, J.Y....
European Urology.  83 (2023)  - p. S1025 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Biology of BCG response in non-muscle invasive bladder canc..:

Reike, M.J. ; Ingersoll, M.A. ; Müller, D.C....
Urologic Oncology: Seminars and Original Investigations.  41 (2023)  5 - p. 211-218 , 2023
Link: https://doi.org/10.1016/..
 
?
8

The CHASIT study: sequential chemo-immunotherapy in patient..:

Rutten, V. C. ; Salhi, Y. ; Robbrecht, G. J....
BMC Cancer.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
9

Targeting NPEPPS overcomes cisplatin resistance in patient-..:

Scholtes, M.P. ; Akbarzadeh, M. ; Romal, S....
European Urology.  83 (2023)  - p. S1696 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Non-muscle invasive bladder cancer subtypes with differenti..:

De Jong, F.C. ; Laajala, T.D. ; Hoedemaeker, R.F....
European Urology.  81 (2022)  - p. S105-S106 , 2022
Link: https://doi.org/10.1016/..
 
?
11

NPEPPS can be targeted to overcome cisplatin resistance in ..:

Scholtes, M.P. ; Akbarzadeh, M. ; Romal, S....
European Urology Open Science.  44 (2022)  - p. S172 , 2022
Link: https://doi.org/10.1016/..
 
?
12

A genomic urine assay to detect urinary tract recurrences i..:

De Jong, F.C. ; Iflé, I.G. ; Kooper, D....
European Urology.  81 (2022)  - p. S1320 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Validation of a GATA2 methylation and FGFR3 mutation assay ..:

Olislagers, M. ; De Jong, F.C. ; Van Etten, V.M.J...
European Urology Open Science.  44 (2022)  - p. S169-S170 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Validation of a GATA2 methylation and FGFR3 mutation assay ..:

Olislagers, M. ; De Jong, F.C. ; Van Etten, V.M.J...
European Urology Open Science.  45 (2022)  - p. S255-S256 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Transcriptome sequencing of BCG-treated T1HG bladder cancer..:

De Jong, F.C. ; Laajala, T.D. ; Hoedemaeker, R.F....
European Urology.  79 (2021)  - p. S612-S613 , 2021
Link: https://doi.org/10.1016/..
 
1-15